Join session

🇬🇧 Oncogenomics + AI :Transcriptomics signatures to allow prognosis and targeted therapy in pancreatic cancer

Nov 22, 2023 — 09:30 am CET - 9:40 AM CET

Presented by

Jean-Baptiste JAUSSAUD

Predicting Med

CEO

Presented by

Jean-Baptiste JAUSSAUD

CEO

In partnership with

Suggested sessions

Nov 22nd

9:00 am CET - 9:25 am CET

Mainstage

🇬🇧 AI for Health 6th edition kick start

Delphine Aguiléra-Caron

Johnson & Johnson Innovative Medicine France

Managing partner and global industry lead for healthcare

Nov 22nd

9:25 am CET - 9:50 am CET

Mainstage

🇬🇧 Virtual cohort, but real recognition by payers?

PSA

Pr Stéphanie Allassonnière

Paris Cité University

Chair PR[AI]RIE & Professor

DJF

Dr Jean-Louis Fraysse

French Ministry of Health & Prevention

Medical Advisor e-Health

Raphaelle Parker

Johnson & Johnson Innovative Medicine

Professor of Biostatistics

Nov 22nd

9:30 am CET - 9:50 am CET

Corporate Masterclass Stage

🇫🇷 Accès au marché DM embarquant de l’IA en santé mentale : quelques questions à se poser ?

DLF

Dr Line Farah

French Ministry of Health & Prevention

Director of Digital Health Challenges for "Mental health" and "Aging well", Digital Health Delegation

Vincent Vercamer

French Ministry of Health & Prevention

Project Director – Market Access expert, Digital Health Delegation

Nov 22nd

9:40 am CET - 9:50 am CET

Startups Masterclass Stage

🇬🇧 Overview of AI Dermatology apps

Kirill Sokol

Skinive

CEO & Founder

Join session

🇬🇧 Oncogenomics + AI :Transcriptomics signatures to allow prognosis and targeted therapy in pancreatic cancer

Nov 22, 2023 — 09:30 am CET - 9:40 AM CET

Presented by

Jean-Baptiste JAUSSAUD

CEO

🇬🇧 AI for Health 6th edition kick start

🇬🇧 Virtual cohort, but real recognition by payers?

🇫🇷 Accès au marché DM embarquant de l’IA en santé mentale :​ quelques questions à se poser ?​

🇬🇧 Overview of AI Dermatology apps

Subscribe to our Newsletter

🇫🇷 Accès au marché DM embarquant de l’IA en santé mentale : quelques questions à se poser ?